Renal effects and nephroprotection induced by SGLT2 inhibitor Empagliflozin in patients with Diabetes Mellitus: a literature review

Renal effects and nephroprotection induced by SGLT2 inhibitor Empagliflozin in patients with Diabetes Mellitus: a literature review

Chronic kidney disease is a frequent comorbidity in patients with diabetes mellitus (DM) and it increases their cardiovascular risk; chronic hyperglycemia in patients with DM leads to direct and indirect disorders in kidney's structure and function, and it is the principal risk factor for the d...

Full description

Bibliographic Details
Main Authors:	Luis E. Morales-Buenrostro, Sonia Citlali Juárez-Comboni, Alma Nelly Rodríguez Alcocer
Format:	Article
Language:	Spanish
Published:	Asociación Regional de Diálisis y Trasplantes Renales de Capital Federal y Provincia de Buenos Aires 2017-01-01
Series:	Revista de Nefrología, Diálisis y Trasplante
Subjects:	enfermedad renal crónica diabetes mellitus nefroprotección empagliflozina
Online Access:	http://www.revistarenal.org.ar/index.php/rndt/article/view/89

Similar Items

¿Qué tan útiles en la práctica diaria para los nefrólogos son los nuevos antidiabéticos con protección cardiovascular?
by: Iván Villegas Gutiérrez
Published: (2017-01-01)

Metformina en enfermedad renal diabética: estado actual
by: José Ildefonzo Arocha Rodulfo, et al.
Published: (2017-08-01)

SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction
by: José Silva-Cardoso, et al.
Published: (2021-09-01)

SGLT2 inhibitors: control of glycemia and nephroprotection properties
by: A. A. Volodin, et al.
Published: (2018-02-01)

SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects
by: Carlo Garofalo, et al.
Published: (2019-06-01)

Empagliflozin: a new strategy for nephroprotection in diabetes
by: Anton Ivanovich Korbut, et al.
Published: (2017-05-01)

CARDIOVASCULAR DISEASE IN PATIENT WITH KIDNEY DISEASE CAUSED BY DIABETES
by: Guillermo Dieuzeide
Published: (2018-08-01)

SGLT-2 inhibitors and nephroprotection: a systematic review and meta-analysis
by: Alda João Araujo Andrade
Published: (2021)

Carga económica de la enfermedad renal crónica en Colombia, 2015-2016
by: HERNÁN SARMIENTO-BEJARANO, et al.
Published: (2019-01-01)

Nephroprotection by SGLT2 Inhibition: Back to the Future?
by: Luca De Nicola, et al.
Published: (2020-07-01)

The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
by: Sebastian Steven, et al.
Published: (2017-10-01)

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
by: Annayya R. Aroor, et al.
Published: (2018-07-01)

Prescribir estatinas a pacientes con enfermedad renal crónica: ¿lo hacemos bien?
by: Frank Lizaraso Caparó, et al.
Published: (2019-04-01)

Marcadores de daño renal en pacientes monorrenos quirúrgicos
by: Tomás de Armas Gil, et al.
Published: (2018-01-01)

Application of Prevention Levels to the Chronic Renal Disease
by: Marta Belkis Núñez López, et al.
Published: (2018-09-01)

Prevención y tratamiento de la enfermedad renal crónica (ERC)
by: B. Rodrigo Orozco, Dr.
Published: (2010-09-01)

The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury
by: Chang Chu, et al.
Published: (2019-04-01)

Afrontamiento a la enfermedad crónica: estudio en pacientes con insuficiencia renal crónica terminal
by: Mónica Cassaretto, et al.
Published: (2006-03-01)

¿Automanejo,autocuidado o autocontrol en enfermedades crónicas?: Acercamiento a su análisis e interpretación
by: Rolando Bonal Ruiz, et al.

Aplicación de los niveles de prevención en la enfermedad renal crónica
by: Marta Belkis Núñez López, et al.
Published: (2018-09-01)

Cystatin C as a Maker of the Renal Function: an Alternative
by: Alexander Benavides Couto, et al.
Published: (2018-12-01)

Enfermedad Renal Crónica: prevenirla, mejor que tratarla
by: Osniel Bencomo Rodríguez

Cystatin C as a Maker of the Renal Function: an Alternative
by: Alexander Benavides Couto, et al.
Published: (2018-12-01)

Prevalencia del consumo de tabaco en pacientes en tratamiento renal sustitutivo: dependencia y actitudes ante el abandono
by: Marta García Pascual, et al.

FUNCIONALIDAD FAMILIAR DESDE LA PERSPECTIVA DE UN INTEGRANTE CON DIABETES MELLITUS TIPO 2 EN LA SIERRA NEGRA DE PUEBLA
by: Reyes, Alejandro Torres, et al.
Published: (2016-12-01)

SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction
by: Ahmed S. Ahmed, et al.
Published: (2021-07-01)

Qualidade de vida de pessoas com insuficiência renal crônica em tratamento hemodialítico
by: Denise Maria Guerreiro Vieira da Silva, et al.
Published: (2002-10-01)

Study of reduced glutathione and malondialdehyde concentrations in patients with chronic renal failure associated with arterial hypertension
by: Adrián Alfonso-Izquierdo, et al.
Published: (2020-03-01)

Study of reduced glutathione and malondialdehyde concentrations in patients with chronic renal failure associated with arterial hypertension
by: Adrián Alfonso-Izquierdo, et al.
Published: (2020-03-01)

Estatinas en enfermedad renal crónica
by: Rodrigo Andrés Sepúlveda Palamara, et al.
Published: (2017-05-01)

Occult renal disease in patients admitted Internal Medicine Service at Dr. Enrique Cabrera General Teaching Hospital
by: Rolando Zamora Fung, et al.
Published: (2019-09-01)

Occult renal disease in patients admitted Internal Medicine Service at Dr. Enrique Cabrera General Teaching Hospital
by: Rolando Zamora Fung, et al.
Published: (2019-09-01)

Documento de consenso para la detección y manejo de la enfermedad renal crónica
by: Alberto Martínez-Castelao, et al.
Published: (2014-11-01)

Diabetes Mellitus (DM) y Enfermedad Pulmonar Obstructiva Crónica (EPOC). Revisión no sistemática. Diabetes mellitus (DM) and Chronic Obstructive Pulmonary Disease (COPD). Non-systematic review
by: Callejas González FJ, et al.
Published: (2018-11-01)

Repetición de la medición de creatinina sérica en atención primaria: no todos tienen insuficiencia renal crónica
by: Delicia Gentille Lorente, et al.
Published: (2015-07-01)

Terapia antihipertensiva en enfermedad renal crónica
by: V. Rodrigo Tagle, Dr.
Published: (2010-07-01)

The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes
by: Francesca Iannantuoni, et al.
Published: (2019-11-01)

Desnutrición en pacientes con enfermedad renal crónica hemodializados en el Hospital Regional de Coronel Oviedo
by: Aldo Ismael Rodríguez Castro, et al.
Published: (2020-08-01)

Prevalencia y factores asociados a enfermedad renal crónica
by: K.A. Guzmán-Guillén, et al.
Published: (2014-07-01)

Resiliencia y enfermedad renal crónica: Una Revisión sistemática
by: Cristina Jazmin Gonzalez Flores, Dr., et al.
Published: (2018-12-01)